Author's posts
6 chief mission officer moves in 2024
Chief mission officers, most common at Catholic hospitals and health systems, focus on preserving religious identity in their organizations. However, their roles can also entail community outreach and involve collaboration with administrative, strategi…
UC Health names CFO, COO and chief clinical officer
Cincinnati-based UC Health has made three changes in its C-suite, hiring one new leader and expanding the roles of two others.
Hospital margins steady at 4.2%, revenue up: 5 details
Nonprofit hospital operating margins further stabilized in August while length of stay decreased, according to Kaufman Hall’s National Hospital Flash Report, published Oct. 2.
PA burnout and depression: 5 notes
More than half of physician assistants say their employer doesn’t recognize burnout and related issues among their staff, according to a new Medscape survey.
10 recent healthcare industry lawsuits, settlements
From UnitedHealthcare suing to prevent CMS from downgrading its Medicare Advantage star ratings, to California’s attorney general suing a hospital after a woman was denied an emergency abortion, here are 10 recent healthcare industry lawsuits, settleme…
Mayo Clinic's $9M cancer center expansion: 4 things to know
Rochester, Minn.-based Mayo Clinic has broken ground on a $9 million cancer center expansion at its New Prague, Minn., medical campus.
Virginia system taps Ensemble for RCM partnership
Fredericksburg, Va.-based Mary Washington Healthcare has selected Ensemble Health Partners for a revenue cycle management partnership.
Trinity rebrands Iowa health system
Livonia, Mich.-based Trinity Health has rebranded Genesis Health System in Davenport, Iowa, as MercyOne Genesis.
AI can do just 5% of jobs, MIT professor warns
Amid the excitement about the possibility of artificial intelligence, the measured voice of Massachusetts Institute of Technology professor Daron Acemoglu, PhD, offers a sobering perspective.
CMS tweaks drug price negotiations for 2025
The second cycle of the Medicare Drug Price Negotiation Program will offer pharma companies more time and chances to submit counteroffers during the price talks, which will take place throughout 2025.
